Application Nr Approved Date Route Status External Links
NDA021738 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Extina (Ketoconazole) Foam, 2% Is Indicated For The Topical Treatment Of Seborrheic Dermatitis In Immunocompetent Patients 12 Years Of Age And Older. Limitations Of Use Safety And Efficacy Of Extina Foam For Treatment Of Fungal Infections Have Not Been Established. Extina ® Foam Is Indicated For Topical Treatment Of Seborrheic Dermatitis In Immunocompetent Patients 12 Years Of Age And Older ( 1 ). Limitations Of Use Safety And Efficacy Of Extina Foam For Treatment Of Fungal Infections Have Not Been Established.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ketoconazole KETOCONAZOLE ZINC643153

Comments